Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV – Get Free Report)’s share price traded down 5% on Wednesday . The company traded as low as $0.42 and last traded at $1.00. 6,119 shares traded hands during trading, an increase of 362% from the average session volume of 1,325 shares. The stock had previously closed at $1.05.
Mosaic ImmunoEngineering Trading Down 5.0%
The firm has a market cap of $7.23 million, a P/E ratio of -9.98 and a beta of -1.11. The business’s fifty day moving average price is $0.62 and its two-hundred day moving average price is $0.54.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last released its quarterly earnings results on Tuesday, August 19th. The company reported ($0.02) earnings per share for the quarter.
Mosaic ImmunoEngineering Company Profile
Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.
Featured Stories
- Five stocks we like better than Mosaic ImmunoEngineering
- How to Profit From Value Investing
- Archer’s Recent String of Victories Signals a New Phase of Growth
- Using the MarketBeat Dividend Yield Calculator
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- When to Sell a Stock for Profit or Loss
- The Best AI for Picking Stocks, Ranked by Performance
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
